Relmada Therapeutics shares owned by Front Row Advisors
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Front Row Advisors
from 13F filings
Historical chart of Front Row Advisors investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Front Row Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Front Row Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4 | 2 | 2.00 |
| 2025-06-30 | $2 | 3 | 0.67 |
| 2025-03-31 | $1 | 6 | 0.33 |
| 2024-09-30 | $19 | 6 | 3.17 |
| 2024-06-30 | $18 | 6 | 3.00 |
| 2024-03-31 | $28 | 6 | 4.67 |
| 2023-12-31 | $25 | 6 | 4.17 |
| 2023-09-30 | $18 | 6 | 3.00 |
| 2023-06-30 | $0 | 6 | 0.00 |
| 2023-03-31 | $0 | 6 | 0.00 |